RGEN
Repligen Corporation · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website repligen.com
- Employees(FY) 2025
- ISIN US7599161095
Performance
+0.79%
1W
-4.78%
1M
-17.97%
3M
+9.64%
6M
-7.95%
YTD
+5.69%
1Y
Profile
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Investment Analysis Report: RGEN
Overview
In this investment analysis report, we will delve into the financial statements of Repligen Corporation (RGEN) to assess its investment potential. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expe...
Technical Analysis of RGEN 2024-05-03
Overview:
In analyzing the technical indicators for RGEN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-07 07:30
- 2024-05-06 19:30
- 2024-05-03 09:35
Repligen First Quarter 2024 Earnings: EPS Misses Expectations(Simply Wall St.)
- 2024-05-02 11:31
- 2024-05-02 11:31
- 2024-05-02 11:23
- 2024-05-01 23:31
- 2024-05-01 23:23
- 2024-05-01 15:06
- 2024-05-01 09:11
- 2024-05-01 08:50
- 2024-05-01 07:47
Repligen: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-01 07:30
Repligen Reports First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-04-30 23:53
- 2024-04-30 20:50
- 2024-04-30 20:47
Repligen's Q1 Adjusted Earnings, Revenue Fall(Yahoo Finance)
- 2024-04-30 19:30
Repligen Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-23 20:00
RGEN: Raising target price to $180.00(Argus Research)
- 2024-04-23 11:43
- 2024-04-22 23:43
- 2024-04-17 07:30
Repligen to Report First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-04-16 19:30
Repligen to Report First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-12 10:07
- 2024-04-11 22:07
- 2024-04-11 21:49
Should You Sell Pool Corporation (POOL)?(Insidermonkey)
- 2024-03-19 07:30
Repligen Appoints Maggie A. Pax to Board of Directors(GlobeNewswire)
- 2024-03-18 19:30
Repligen Appoints Maggie A. Pax to Board of Directors(Globenewswire)
- 2024-03-18 10:30
- 2024-03-12 01:18
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares(GuruFocus.com)
- 2024-03-04 11:40
Page 1 of 6
previousnext